Cambridge Investment Research Advisors, Inc. Orgenesis Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $26 Billion
- Q1 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Orgenesis Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 18,330 shares of ORGS stock, worth $11,914. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,330
Previous 18,330
-0.0%
Holding current value
$11,914
Previous $9,000
66.67%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ORGS
# of Institutions
18Shares Held
1.63MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA925KShares$601,3230.0% of portfolio
-
Geode Capital Management, LLC Boston, MA288KShares$187,1700.0% of portfolio
-
Black Rock Inc. New York, NY125KShares$81,3960.0% of portfolio
-
State Street Corp Boston, MA67.7KShares$43,9780.0% of portfolio
-
Ronit Capital LLP54.2KShares$35,2080.1% of portfolio
About Orgenesis Inc.
- Ticker ORGS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,545,800
- Market Cap $16.6M
- Description
- Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...